drugset
drugset / Trial / NCT07543224

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

NCT07543224 ↗

Phase 3 Not yet recruiting 600 enrolled Reistone Biopharma Company Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase III Efficacy and Safety Study of RSS0393 Ointment in Plaque Psoriasis.

Timeline

Start
2026-04
Primary completion
2027-01
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject RSS0393 Unknown 0.03 % —

Indications

psoriasis